ArticlePloS one2018

Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice.

Ryo Kawakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.